1. Home
  2. WGSWW vs CXAIW Comparison

WGSWW vs CXAIW Comparison

Compare WGSWW & CXAIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GeneDx Holdings Corp.

WGSWW

GeneDx Holdings Corp.

N/A

Current Price

$0.01

Market Cap

0.0

Sector

Technology

ML Signal

N/A

Logo CXApp Inc. Warrant

CXAIW

CXApp Inc. Warrant

HOLD

Current Price

$0.06

Market Cap

0.0

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
WGSWW
CXAIW
Founded
2017
N/A
Country
United States
United States
Employees
1300
35
Industry
Retail: Computer Software & Peripheral Equipment
EDP Services
Sector
Technology
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
WGSWW
CXAIW
Price
$0.01
$0.06
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
118.0K
70.5K
Earning Date
02-18-2025
03-21-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$305,450,000.00
$7,200,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
50.79
N/A
52 Week Low
$0.00
$0.02
52 Week High
$0.13
$0.13

Technical Indicators

Market Signals
Indicator
WGSWW
CXAIW
Relative Strength Index (RSI) 56.38 62.42
Support Level $0.00 $0.03
Resistance Level $0.02 $0.08
Average True Range (ATR) 0.00 0.01
MACD 0.00 0.00
Stochastic Oscillator 64.18 59.12

Price Performance

Historical Comparison
WGSWW
CXAIW

About WGSWW GeneDx Holdings Corp.

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

About CXAIW CXApp Inc. Warrant

CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. Its cloud-based, mobile-first platform integrates artificial intelligence, automation, and real-time analytics to streamline workplace interactions across people, spaces, and technology. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, Agentic AI Capabilities, and CXAI-VU. The company generates the majority of its revenue from Licenses.

Share on Social Networks: